The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-10-21

AUTHORS

Paolo A Ascierto, Raffaele Addeo, Giacomo Cartenì, Bruno Daniele, Michele De Laurentis, Giovanni Pietro Ianniello, Alessandro Morabito, Giovannella Palmieri, Stefano Pepe, Francesco Perrone, Sandro Pignata, Vincenzo Montesarchio

ABSTRACT

The therapeutic approach to advanced or metastatic solid tumors, either with chemotherapy or targeted therapies, is mainly palliative. Resistance to chemotherapy occurs very frequently and is one of the most important reasons for disease progression. Immunotherapy has the potential to mount an ongoing, dynamic immune response that can kill tumor cells for an extended time after the conventional therapy has been administered. Such a long-lasting response is potentially able to completely eradicate tumor cells, rather than producing only a temporary killing of cells. The most promising immune-based treatments are monoclonal antibodies that act as checkpoint inhibitors (e.g. ipilimumab and nivolumab), adoptive cell therapy (e.g. T-cells expressing chimeric antigen receptors) and vaccines (e.g. sipuleucel-T). Ipilimumab is currently approved for the treatment of metastatic melanoma and sipuleucel-T is approved for advanced prostate cancer. There is great interest in immunotherapy in other solid tumors, potentially used alone or in a multimodal fashion with chemotherapy and/or biological drugs. In this paper, we review recent advances in immuno-oncology in solid malignancies (except melanoma) as were discussed at the inaugural meeting of the Campania Society of Oncology Immunotherapy (SCITO). More... »

PAGES

291

References to SciGraph publications

  • 2009-01-13. Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2008-02-23. FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy in BMC CANCER
  • 2008-06. Inhibitory B7-family molecules in the tumour microenvironment in NATURE REVIEWS IMMUNOLOGY
  • 2011-03-14. AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme in ADVANCES IN THERAPY
  • 2014-05-07. Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2002-07-09. Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival in BRITISH JOURNAL OF CANCER
  • 2006-01-17. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma in BRITISH JOURNAL OF CANCER
  • 2002-01-10. Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2013-02-18. Immune cell profile of sentinel lymph nodes in patients with malignant melanoma – FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2007-12-12. Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma in JOURNAL OF TRANSLATIONAL MEDICINE
  • Journal

    TITLE

    Journal of Translational Medicine

    ISSUE

    1

    VOLUME

    12

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12967-014-0291-1

    DOI

    http://dx.doi.org/10.1186/s12967-014-0291-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1008604592

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/25331657


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Clinical Trials as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Congresses as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Endpoint Determination", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunotherapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasms", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, 80131, Via Mariano Semmola, Naples, Italy", 
              "id": "http://www.grid.ac/institutes/grid.508451.d", 
              "name": [
                "Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, 80131, Via Mariano Semmola, Naples, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ascierto", 
            "givenName": "Paolo A", 
            "id": "sg:person.01212502023.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212502023.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unit of Oncology, Ospedale \u201cSan Giovanni di Dio\u201d, Frattamaggiore, NA, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Unit of Oncology, Ospedale \u201cSan Giovanni di Dio\u201d, Frattamaggiore, NA, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Addeo", 
            "givenName": "Raffaele", 
            "id": "sg:person.0620235357.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620235357.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unit of Medical Oncology, Dipartimento di Oncopneumoematologia, A.O.R.N. \u201cA. Cardarelli\u201d, Naples, Italy", 
              "id": "http://www.grid.ac/institutes/grid.413172.2", 
              "name": [
                "Unit of Medical Oncology, Dipartimento di Oncopneumoematologia, A.O.R.N. \u201cA. Cardarelli\u201d, Naples, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Carten\u00ec", 
            "givenName": "Giacomo", 
            "id": "sg:person.01370613756.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370613756.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Oncology, A.O. \u201cG. Rummo\u201d, Benevento, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Oncology, A.O. \u201cG. Rummo\u201d, Benevento, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Daniele", 
            "givenName": "Bruno", 
            "id": "sg:person.01231504560.97", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231504560.97"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unit\u00e0 Oncologia Medica Senologica, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, Naples, Italy", 
              "id": "http://www.grid.ac/institutes/grid.508451.d", 
              "name": [
                "Unit\u00e0 Oncologia Medica Senologica, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, Naples, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "De Laurentis", 
            "givenName": "Michele", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Oncology, A.O.R.N. \u201cS. Anna e S. Sebastiano\u201d, Caserta, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Oncology, A.O.R.N. \u201cS. Anna e S. Sebastiano\u201d, Caserta, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ianniello", 
            "givenName": "Giovanni Pietro", 
            "id": "sg:person.0642647507.68", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642647507.68"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unit\u00e0 Oncologia Medica Toraco-Polmonare, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, Naples, Italy", 
              "id": "http://www.grid.ac/institutes/grid.508451.d", 
              "name": [
                "Unit\u00e0 Oncologia Medica Toraco-Polmonare, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, Naples, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Morabito", 
            "givenName": "Alessandro", 
            "id": "sg:person.015407411102.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015407411102.31"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular and Clinical Endocrinology and Oncology, University \u201cFederico II\u201d, Naples, Italy", 
              "id": "http://www.grid.ac/institutes/grid.4691.a", 
              "name": [
                "Department of Molecular and Clinical Endocrinology and Oncology, University \u201cFederico II\u201d, Naples, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Palmieri", 
            "givenName": "Giovannella", 
            "id": "sg:person.013410566277.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013410566277.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dipartimento di Medicina e Chirurgia, A.O.U. \u201cSan Giovanni di Dio e Ruggi d\u2019Aragona\u201d, University of Salerno, Salerno, Italy", 
              "id": "http://www.grid.ac/institutes/grid.11780.3f", 
              "name": [
                "Dipartimento di Medicina e Chirurgia, A.O.U. \u201cSan Giovanni di Dio e Ruggi d\u2019Aragona\u201d, University of Salerno, Salerno, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pepe", 
            "givenName": "Stefano", 
            "id": "sg:person.01222214702.83", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222214702.83"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unit\u00e0 Sperimentazioni Cliniche, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, Napoli, Italy", 
              "id": "http://www.grid.ac/institutes/grid.508451.d", 
              "name": [
                "Unit\u00e0 Sperimentazioni Cliniche, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, Napoli, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Perrone", 
            "givenName": "Francesco", 
            "id": "sg:person.0577451344.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577451344.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dipartimento di Oncologia Uroginecologica, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, Naples, Italy", 
              "id": "http://www.grid.ac/institutes/grid.508451.d", 
              "name": [
                "Dipartimento di Oncologia Uroginecologica, Istituto Nazionale Tumori Fondazione \u201cG. Pascale\u201d, Naples, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pignata", 
            "givenName": "Sandro", 
            "id": "sg:person.015104146754.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015104146754.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unit of Oncology, A.O.R.N. dei COLLI \u201cOspedali Monaldi-Cotugno-CTO\u201d, Naples, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Unit of Oncology, A.O.R.N. dei COLLI \u201cOspedali Monaldi-Cotugno-CTO\u201d, Naples, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Montesarchio", 
            "givenName": "Vincenzo", 
            "id": "sg:person.01230424371.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230424371.42"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00262-001-0255-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032848375", 
              "https://doi.org/10.1007/s00262-001-0255-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1479-5876-5-66", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043990539", 
              "https://doi.org/10.1186/1479-5876-5-66"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nri2326", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033022245", 
              "https://doi.org/10.1038/nri2326"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6600437", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013831470", 
              "https://doi.org/10.1038/sj.bjc.6600437"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00262-008-0642-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015704592", 
              "https://doi.org/10.1007/s00262-008-0642-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2407-8-57", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043590884", 
              "https://doi.org/10.1186/1471-2407-8-57"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6602934", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028524139", 
              "https://doi.org/10.1038/sj.bjc.6602934"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1479-5876-12-116", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049608203", 
              "https://doi.org/10.1186/1479-5876-12-116"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1479-5876-11-43", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017218099", 
              "https://doi.org/10.1186/1479-5876-11-43"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12325-011-0007-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037365997", 
              "https://doi.org/10.1007/s12325-011-0007-3"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2014-10-21", 
        "datePublishedReg": "2014-10-21", 
        "description": "The therapeutic approach to advanced or metastatic solid tumors, either with chemotherapy or targeted therapies, is mainly palliative. Resistance to chemotherapy occurs very frequently and is one of the most important reasons for disease progression. Immunotherapy has the potential to mount an ongoing, dynamic immune response that can kill tumor cells for an extended time after the conventional therapy has been administered. Such a long-lasting response is potentially able to completely eradicate tumor cells, rather than producing only a temporary killing of cells. The most promising immune-based treatments are monoclonal antibodies that act as checkpoint inhibitors (e.g. ipilimumab and nivolumab), adoptive cell therapy (e.g. T-cells expressing chimeric antigen receptors) and vaccines (e.g. sipuleucel-T). Ipilimumab is currently approved for the treatment of metastatic melanoma and sipuleucel-T is approved for advanced prostate cancer. There is great interest in immunotherapy in other solid tumors, potentially used alone or in a multimodal fashion with chemotherapy and/or biological drugs. In this paper, we review recent advances in immuno-oncology in solid malignancies (except melanoma) as were discussed at the inaugural meeting of the Campania Society of Oncology Immunotherapy (SCITO).", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s12967-014-0291-1", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1032886", 
            "issn": [
              "1479-5876"
            ], 
            "name": "Journal of Translational Medicine", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "12"
          }
        ], 
        "keywords": [
          "solid tumors", 
          "tumor cells", 
          "role of immunotherapy", 
          "metastatic solid tumors", 
          "advanced prostate cancer", 
          "immune-based treatments", 
          "dynamic immune responses", 
          "adoptive cell therapy", 
          "Oncology Immunotherapy", 
          "checkpoint inhibitors", 
          "conventional therapy", 
          "metastatic melanoma", 
          "solid malignancies", 
          "disease progression", 
          "prostate cancer", 
          "immune response", 
          "therapeutic approaches", 
          "immunotherapy", 
          "biological drugs", 
          "cell therapy", 
          "monoclonal antibodies", 
          "therapy", 
          "tumors", 
          "chemotherapy", 
          "treatment", 
          "cells", 
          "multimodal fashion", 
          "ipilimumab", 
          "sipuleucel", 
          "malignancy", 
          "vaccine", 
          "melanoma", 
          "cancer", 
          "progression", 
          "antibodies", 
          "response", 
          "drugs", 
          "inhibitors", 
          "recent advances", 
          "inaugural meeting", 
          "important reason", 
          "killing", 
          "extended time", 
          "meeting", 
          "role", 
          "resistance", 
          "fashion", 
          "advances", 
          "reasons", 
          "time", 
          "potential", 
          "society", 
          "great interest", 
          "interest", 
          "approach", 
          "paper"
        ], 
        "name": "The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014", 
        "pagination": "291", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1008604592"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12967-014-0291-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "25331657"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12967-014-0291-1", 
          "https://app.dimensions.ai/details/publication/pub.1008604592"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:39", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_644.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s12967-014-0291-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0291-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0291-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0291-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12967-014-0291-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    286 TRIPLES      21 PREDICATES      98 URIs      79 LITERALS      13 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12967-014-0291-1 schema:about N2d78c451182c45a8b8beeff3c3b46c37
    2 N6fda8817da9c4e57ac49efba561cadf6
    3 N86e374effac54c40857ba267f703cf95
    4 Nb665d401b80c4703919c2f8832d090f8
    5 Ne35ae13fcd65421fbcb1a18b4eea7ccb
    6 Nffb3c7497fc74cc4809eae514d90df89
    7 anzsrc-for:11
    8 anzsrc-for:1107
    9 anzsrc-for:1112
    10 schema:author N35a0c6c1d9f249808627f44977bdbbce
    11 schema:citation sg:pub.10.1007/s00262-001-0255-1
    12 sg:pub.10.1007/s00262-008-0642-y
    13 sg:pub.10.1007/s12325-011-0007-3
    14 sg:pub.10.1038/nri2326
    15 sg:pub.10.1038/sj.bjc.6600437
    16 sg:pub.10.1038/sj.bjc.6602934
    17 sg:pub.10.1186/1471-2407-8-57
    18 sg:pub.10.1186/1479-5876-11-43
    19 sg:pub.10.1186/1479-5876-12-116
    20 sg:pub.10.1186/1479-5876-5-66
    21 schema:datePublished 2014-10-21
    22 schema:datePublishedReg 2014-10-21
    23 schema:description The therapeutic approach to advanced or metastatic solid tumors, either with chemotherapy or targeted therapies, is mainly palliative. Resistance to chemotherapy occurs very frequently and is one of the most important reasons for disease progression. Immunotherapy has the potential to mount an ongoing, dynamic immune response that can kill tumor cells for an extended time after the conventional therapy has been administered. Such a long-lasting response is potentially able to completely eradicate tumor cells, rather than producing only a temporary killing of cells. The most promising immune-based treatments are monoclonal antibodies that act as checkpoint inhibitors (e.g. ipilimumab and nivolumab), adoptive cell therapy (e.g. T-cells expressing chimeric antigen receptors) and vaccines (e.g. sipuleucel-T). Ipilimumab is currently approved for the treatment of metastatic melanoma and sipuleucel-T is approved for advanced prostate cancer. There is great interest in immunotherapy in other solid tumors, potentially used alone or in a multimodal fashion with chemotherapy and/or biological drugs. In this paper, we review recent advances in immuno-oncology in solid malignancies (except melanoma) as were discussed at the inaugural meeting of the Campania Society of Oncology Immunotherapy (SCITO).
    24 schema:genre article
    25 schema:isAccessibleForFree true
    26 schema:isPartOf N196d9c4f45be4685ba4747af0ceccf42
    27 Nf10d9f6d2e1643af882528feedcdb6b9
    28 sg:journal.1032886
    29 schema:keywords Oncology Immunotherapy
    30 adoptive cell therapy
    31 advanced prostate cancer
    32 advances
    33 antibodies
    34 approach
    35 biological drugs
    36 cancer
    37 cell therapy
    38 cells
    39 checkpoint inhibitors
    40 chemotherapy
    41 conventional therapy
    42 disease progression
    43 drugs
    44 dynamic immune responses
    45 extended time
    46 fashion
    47 great interest
    48 immune response
    49 immune-based treatments
    50 immunotherapy
    51 important reason
    52 inaugural meeting
    53 inhibitors
    54 interest
    55 ipilimumab
    56 killing
    57 malignancy
    58 meeting
    59 melanoma
    60 metastatic melanoma
    61 metastatic solid tumors
    62 monoclonal antibodies
    63 multimodal fashion
    64 paper
    65 potential
    66 progression
    67 prostate cancer
    68 reasons
    69 recent advances
    70 resistance
    71 response
    72 role
    73 role of immunotherapy
    74 sipuleucel
    75 society
    76 solid malignancies
    77 solid tumors
    78 therapeutic approaches
    79 therapy
    80 time
    81 treatment
    82 tumor cells
    83 tumors
    84 vaccine
    85 schema:name The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014
    86 schema:pagination 291
    87 schema:productId N6e9e2fa109a94817b946ca152ccf71c6
    88 Nab9cea6294c54f7f9c485aa84d6e3996
    89 Nebe8d95ff67b4d259eb289a38fd1b982
    90 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008604592
    91 https://doi.org/10.1186/s12967-014-0291-1
    92 schema:sdDatePublished 2022-10-01T06:39
    93 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    94 schema:sdPublisher Nb7d9e7bccf894f268c578bcea2d3929e
    95 schema:url https://doi.org/10.1186/s12967-014-0291-1
    96 sgo:license sg:explorer/license/
    97 sgo:sdDataset articles
    98 rdf:type schema:ScholarlyArticle
    99 N196d9c4f45be4685ba4747af0ceccf42 schema:issueNumber 1
    100 rdf:type schema:PublicationIssue
    101 N1a24ae015799409f90fbc14c7e6831f9 rdf:first sg:person.01230424371.42
    102 rdf:rest rdf:nil
    103 N2d78c451182c45a8b8beeff3c3b46c37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    104 schema:name Immunotherapy
    105 rdf:type schema:DefinedTerm
    106 N35a0c6c1d9f249808627f44977bdbbce rdf:first sg:person.01212502023.44
    107 rdf:rest N35ae10120cf841ae9a45b834fba5bb87
    108 N35ae10120cf841ae9a45b834fba5bb87 rdf:first sg:person.0620235357.42
    109 rdf:rest N55e76770a87f47edb76c756db60e7fe3
    110 N388939afe0e4493bae43560c71aae934 schema:affiliation grid-institutes:grid.508451.d
    111 schema:familyName De Laurentis
    112 schema:givenName Michele
    113 rdf:type schema:Person
    114 N40b9c7b419f84c51b14c63980517a6b5 rdf:first sg:person.0642647507.68
    115 rdf:rest N965eb1bdb6d4413ea787e68c938c76bc
    116 N4ed84e20c1564ae4a49eac146616cc0b rdf:first sg:person.013410566277.16
    117 rdf:rest N7d6343f1a4714d7bbb0a32a2cd46ddcc
    118 N55e76770a87f47edb76c756db60e7fe3 rdf:first sg:person.01370613756.53
    119 rdf:rest Nb0d9506f8c1e4889b4d8eed81ebb44ae
    120 N64c60f1df07f428c82bb02c14bda733f rdf:first sg:person.015104146754.43
    121 rdf:rest N1a24ae015799409f90fbc14c7e6831f9
    122 N6e9e2fa109a94817b946ca152ccf71c6 schema:name doi
    123 schema:value 10.1186/s12967-014-0291-1
    124 rdf:type schema:PropertyValue
    125 N6fda8817da9c4e57ac49efba561cadf6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name Clinical Trials as Topic
    127 rdf:type schema:DefinedTerm
    128 N74dd8d2b4e9242708e0626a706d1c9f7 rdf:first sg:person.0577451344.32
    129 rdf:rest N64c60f1df07f428c82bb02c14bda733f
    130 N7d2b7c939cc642349f1c52b4f429bf69 rdf:first N388939afe0e4493bae43560c71aae934
    131 rdf:rest N40b9c7b419f84c51b14c63980517a6b5
    132 N7d6343f1a4714d7bbb0a32a2cd46ddcc rdf:first sg:person.01222214702.83
    133 rdf:rest N74dd8d2b4e9242708e0626a706d1c9f7
    134 N86e374effac54c40857ba267f703cf95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Endpoint Determination
    136 rdf:type schema:DefinedTerm
    137 N965eb1bdb6d4413ea787e68c938c76bc rdf:first sg:person.015407411102.31
    138 rdf:rest N4ed84e20c1564ae4a49eac146616cc0b
    139 Nab9cea6294c54f7f9c485aa84d6e3996 schema:name dimensions_id
    140 schema:value pub.1008604592
    141 rdf:type schema:PropertyValue
    142 Nb0d9506f8c1e4889b4d8eed81ebb44ae rdf:first sg:person.01231504560.97
    143 rdf:rest N7d2b7c939cc642349f1c52b4f429bf69
    144 Nb665d401b80c4703919c2f8832d090f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Humans
    146 rdf:type schema:DefinedTerm
    147 Nb7d9e7bccf894f268c578bcea2d3929e schema:name Springer Nature - SN SciGraph project
    148 rdf:type schema:Organization
    149 Ne35ae13fcd65421fbcb1a18b4eea7ccb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Congresses as Topic
    151 rdf:type schema:DefinedTerm
    152 Nebe8d95ff67b4d259eb289a38fd1b982 schema:name pubmed_id
    153 schema:value 25331657
    154 rdf:type schema:PropertyValue
    155 Nf10d9f6d2e1643af882528feedcdb6b9 schema:volumeNumber 12
    156 rdf:type schema:PublicationVolume
    157 Nffb3c7497fc74cc4809eae514d90df89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Neoplasms
    159 rdf:type schema:DefinedTerm
    160 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    161 schema:name Medical and Health Sciences
    162 rdf:type schema:DefinedTerm
    163 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    164 schema:name Immunology
    165 rdf:type schema:DefinedTerm
    166 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    167 schema:name Oncology and Carcinogenesis
    168 rdf:type schema:DefinedTerm
    169 sg:journal.1032886 schema:issn 1479-5876
    170 schema:name Journal of Translational Medicine
    171 schema:publisher Springer Nature
    172 rdf:type schema:Periodical
    173 sg:person.01212502023.44 schema:affiliation grid-institutes:grid.508451.d
    174 schema:familyName Ascierto
    175 schema:givenName Paolo A
    176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212502023.44
    177 rdf:type schema:Person
    178 sg:person.01222214702.83 schema:affiliation grid-institutes:grid.11780.3f
    179 schema:familyName Pepe
    180 schema:givenName Stefano
    181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222214702.83
    182 rdf:type schema:Person
    183 sg:person.01230424371.42 schema:affiliation grid-institutes:None
    184 schema:familyName Montesarchio
    185 schema:givenName Vincenzo
    186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230424371.42
    187 rdf:type schema:Person
    188 sg:person.01231504560.97 schema:affiliation grid-institutes:None
    189 schema:familyName Daniele
    190 schema:givenName Bruno
    191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231504560.97
    192 rdf:type schema:Person
    193 sg:person.013410566277.16 schema:affiliation grid-institutes:grid.4691.a
    194 schema:familyName Palmieri
    195 schema:givenName Giovannella
    196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013410566277.16
    197 rdf:type schema:Person
    198 sg:person.01370613756.53 schema:affiliation grid-institutes:grid.413172.2
    199 schema:familyName Cartenì
    200 schema:givenName Giacomo
    201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370613756.53
    202 rdf:type schema:Person
    203 sg:person.015104146754.43 schema:affiliation grid-institutes:grid.508451.d
    204 schema:familyName Pignata
    205 schema:givenName Sandro
    206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015104146754.43
    207 rdf:type schema:Person
    208 sg:person.015407411102.31 schema:affiliation grid-institutes:grid.508451.d
    209 schema:familyName Morabito
    210 schema:givenName Alessandro
    211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015407411102.31
    212 rdf:type schema:Person
    213 sg:person.0577451344.32 schema:affiliation grid-institutes:grid.508451.d
    214 schema:familyName Perrone
    215 schema:givenName Francesco
    216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577451344.32
    217 rdf:type schema:Person
    218 sg:person.0620235357.42 schema:affiliation grid-institutes:None
    219 schema:familyName Addeo
    220 schema:givenName Raffaele
    221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620235357.42
    222 rdf:type schema:Person
    223 sg:person.0642647507.68 schema:affiliation grid-institutes:None
    224 schema:familyName Ianniello
    225 schema:givenName Giovanni Pietro
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642647507.68
    227 rdf:type schema:Person
    228 sg:pub.10.1007/s00262-001-0255-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032848375
    229 https://doi.org/10.1007/s00262-001-0255-1
    230 rdf:type schema:CreativeWork
    231 sg:pub.10.1007/s00262-008-0642-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1015704592
    232 https://doi.org/10.1007/s00262-008-0642-y
    233 rdf:type schema:CreativeWork
    234 sg:pub.10.1007/s12325-011-0007-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037365997
    235 https://doi.org/10.1007/s12325-011-0007-3
    236 rdf:type schema:CreativeWork
    237 sg:pub.10.1038/nri2326 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033022245
    238 https://doi.org/10.1038/nri2326
    239 rdf:type schema:CreativeWork
    240 sg:pub.10.1038/sj.bjc.6600437 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013831470
    241 https://doi.org/10.1038/sj.bjc.6600437
    242 rdf:type schema:CreativeWork
    243 sg:pub.10.1038/sj.bjc.6602934 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028524139
    244 https://doi.org/10.1038/sj.bjc.6602934
    245 rdf:type schema:CreativeWork
    246 sg:pub.10.1186/1471-2407-8-57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043590884
    247 https://doi.org/10.1186/1471-2407-8-57
    248 rdf:type schema:CreativeWork
    249 sg:pub.10.1186/1479-5876-11-43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017218099
    250 https://doi.org/10.1186/1479-5876-11-43
    251 rdf:type schema:CreativeWork
    252 sg:pub.10.1186/1479-5876-12-116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049608203
    253 https://doi.org/10.1186/1479-5876-12-116
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1186/1479-5876-5-66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043990539
    256 https://doi.org/10.1186/1479-5876-5-66
    257 rdf:type schema:CreativeWork
    258 grid-institutes:None schema:alternateName Department of Oncology, A.O. “G. Rummo”, Benevento, Italy
    259 Department of Oncology, A.O.R.N. “S. Anna e S. Sebastiano”, Caserta, Italy
    260 Unit of Oncology, A.O.R.N. dei COLLI “Ospedali Monaldi-Cotugno-CTO”, Naples, Italy
    261 Unit of Oncology, Ospedale “San Giovanni di Dio”, Frattamaggiore, NA, Italy
    262 schema:name Department of Oncology, A.O. “G. Rummo”, Benevento, Italy
    263 Department of Oncology, A.O.R.N. “S. Anna e S. Sebastiano”, Caserta, Italy
    264 Unit of Oncology, A.O.R.N. dei COLLI “Ospedali Monaldi-Cotugno-CTO”, Naples, Italy
    265 Unit of Oncology, Ospedale “San Giovanni di Dio”, Frattamaggiore, NA, Italy
    266 rdf:type schema:Organization
    267 grid-institutes:grid.11780.3f schema:alternateName Dipartimento di Medicina e Chirurgia, A.O.U. “San Giovanni di Dio e Ruggi d’Aragona”, University of Salerno, Salerno, Italy
    268 schema:name Dipartimento di Medicina e Chirurgia, A.O.U. “San Giovanni di Dio e Ruggi d’Aragona”, University of Salerno, Salerno, Italy
    269 rdf:type schema:Organization
    270 grid-institutes:grid.413172.2 schema:alternateName Unit of Medical Oncology, Dipartimento di Oncopneumoematologia, A.O.R.N. “A. Cardarelli”, Naples, Italy
    271 schema:name Unit of Medical Oncology, Dipartimento di Oncopneumoematologia, A.O.R.N. “A. Cardarelli”, Naples, Italy
    272 rdf:type schema:Organization
    273 grid-institutes:grid.4691.a schema:alternateName Department of Molecular and Clinical Endocrinology and Oncology, University “Federico II”, Naples, Italy
    274 schema:name Department of Molecular and Clinical Endocrinology and Oncology, University “Federico II”, Naples, Italy
    275 rdf:type schema:Organization
    276 grid-institutes:grid.508451.d schema:alternateName Dipartimento di Oncologia Uroginecologica, Istituto Nazionale Tumori Fondazione “G. Pascale”, Naples, Italy
    277 Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione “G. Pascale”, 80131, Via Mariano Semmola, Naples, Italy
    278 Unità Oncologia Medica Senologica, Istituto Nazionale Tumori Fondazione “G. Pascale”, Naples, Italy
    279 Unità Oncologia Medica Toraco-Polmonare, Istituto Nazionale Tumori Fondazione “G. Pascale”, Naples, Italy
    280 Unità Sperimentazioni Cliniche, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
    281 schema:name Dipartimento di Oncologia Uroginecologica, Istituto Nazionale Tumori Fondazione “G. Pascale”, Naples, Italy
    282 Unit of Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori Fondazione “G. Pascale”, 80131, Via Mariano Semmola, Naples, Italy
    283 Unità Oncologia Medica Senologica, Istituto Nazionale Tumori Fondazione “G. Pascale”, Naples, Italy
    284 Unità Oncologia Medica Toraco-Polmonare, Istituto Nazionale Tumori Fondazione “G. Pascale”, Naples, Italy
    285 Unità Sperimentazioni Cliniche, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
    286 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...